The Lancet Psychiatry
Discover clinical research, reviews, and provacative comment and opinion from The Lancet Psychiatry, providing a clear, independent perspective about clinical advances and practice-changing research
Related Articles
Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignancies
The increasing use of immunotherapeutic approaches, cellular therapies, and targeted agents is rapidly and profoundly changing the treatment paradigms of haematological malignancies. These novel therapies…
The Lancet Specialty Collections: Oncology
Stay up to date in your field with our Oncology Collection. Explore all related content published across The Lancet Group. The Lancet Child & Adolescent Health…
The missing link in the NCD agenda: girls and young women remain overlooked
An update to the original 2016 Commission, this second iteration of The Lancet Commission on adolescent health and wellbeing presents crucial data on the challenges…
Special issue on neurology: call for papers
Neurological disorders are the leading cause of disease burden, affecting more than 3 billion people worldwide, and the second leading cause of death.1 The burden…
Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial
Our results show that the outcome in individuals with gestational diabetes is not improved by the use of rtCGM. However, individuals expressed a higher preference…
Continuous glucose monitoring in gestational diabetes
Gestational diabetes affects between 7·1–27·6% of pregnancies, depending on the global region.1 Management effectively reduces complications in both early2 and late3 pregnancy and includes education,…
Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis
Current interventions bring about improvements in medication adherence, but such improvements are not sustained over the long-term. For real world and practice implications, interventions must…
ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial
In patients with symptomatic severe aortic stenosis, TAVR with ACURATE neo2 did not meet non-inferiority and resulted in significantly worse outcomes with respect to the…
Overlooked and under-reported: the impact of cyberattacks on primary care in the UK National Health Service
Rapid digitisation and interconnectivity of the UK National Health Service (NHS) among hospital trusts, general practices, and patients help to streamline patient care across sectors.1…
When data disappear: public health pays as US policy strays
Presidential actions on Jan 20, 2025, by President Donald Trump, including executive orders, have delayed access to or led to the removal of crucial public…